Loading
Latest filing published 13 Oct 2026 for Retension Pharmaceuticals, Inc.. Read the official filing
No signal scores available.
Sabine Bisson appears in our data through filings on Retension Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated 13 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 13 October 2026: a transaction, in Retension Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations